Reported Oct 15, 2014 · Terminated
Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only,…
Gilead Sciences, Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Gilead Sciences, Inc. · 333 Lakeside Dr · Foster City, CA · 94404-1147
Is this the product you have?
- Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1
- Lot codes and dates
TRUVADA (NDA 21-752NDC 61958-0701-1) Lot# 002808
- Expiration Date31 December 2017
- Amount recalled
- 10,317 bottles
Where it was sold
- Nationwide
Why it was recalled
Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Gilead Sciences, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.